WallStSmart
BHVN

Biohaven Pharmaceutical Holding Co Ltd

NYSE: BHVN · HEALTHCARE · BIOTECHNOLOGY

$9.20
-4.27% today

Updated 2026-04-29

Market cap
$1.38B
P/E ratio
P/S ratio
EPS (TTM)
$-6.86
Dividend yield
52W range
$7 – $24
Volume
2.2M

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+2.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+47.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.4%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-8.6%
2025-08-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.90+23.7%$9.09$8.93-1.8%
2025-11-10$-1.64+12.8%$8.26$8.52+3.1%
2025-08-11$-1.94+0.0%$14.74$13.47-8.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.18$-0.90+23.7%
2025-09-30$-1.88$-1.64+12.8%
2025-06-30$-1.94$-1.94+0.0%
2025-03-31$-1.70$-2.17-27.6%
2024-12-31$-1.60$-1.71-6.9%$3.84M
2024-09-30$-1.70$-1.74-2.4%
2024-06-30$-1.78$-3.50-96.6%
2024-03-31$-1.57$-2.20-40.1%
2023-12-31$-1.41$-1.81-28.4%
2023-09-30$-1.34$-1.50-11.9%
2023-06-30$-1.21$-1.32-9.1%

Frequently asked questions

Has Biohaven Pharmaceutical Holding Co Ltd beaten earnings estimates?
Biohaven Pharmaceutical Holding Co Ltd has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +2.2% over the last 4 quarters.
How does BHVN stock react to earnings?
BHVN stock has moved an average of -2.4% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.